Gamida Cell Ltd. (GMDA) Announces Proposed Common Share Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- Lula, Brazil's iconic working class president, wins historic fourth term in dramatic comeback
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
- Accenture shares fall on insider sales and analyst downgrade
- Wall Street closes lower to end rocky week
- Credo Technology shares fall on competition concerns
Gamida Cell (GMDA) Prices $65 Million Public Offering of Ordinary Shares at $8/sh
December 17, 2020 9:46 AM ESTGamida Cell Ltd. (Nasdaq: GMDA), an advanced cell therapy company committed to cures for blood cancers and serious hematologic diseases, today announced the pricing of a follow-on public offering of 8,125,000 ordinary shares at a public offering price of $8.00 per share for aggregate gross proceeds of $65.0... More
Gamida Cell Ltd. (GMDA) PT Lowered to $17 at Oppenheimer
December 15, 2020 7:17 AM ESTOppenheimer analyst Mark Briedenbach lowered the price target on Gamida Cell Ltd. (NASDAQ: GMDA) to $17.00 (from $20.00) while maintaining a Outperform rating.... More
Gamida Cell Ltd. (GMDA) PT Lowered to $12 at RBC Capital
December 15, 2020 6:15 AM ESTRBC Capital analyst Gregory Renza lowered the price target on Gamida Cell Ltd. (NASDAQ: GMDA) to $12.00 (from $13.00) while maintaining a Outperform rating.... More



